Katherine J Brempelis

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin P Labadie, Shannon A Kreuser, Katherine J Brempelis, Sara K Daniel, Xiuyun Jiang, Kevin M Sullivan, Alan F Utria, Heidi L Kenerson, Teresa S Kim, Courtney A Crane, Venu G Pillarisetty
Production of an interleukin-10 blocking antibody by genetically engineered macrophages increases cancer cell death in human gastrointestinal tumor slice cultures. Cancer gene therapy (2023)
Ciana L López, Katherine J Brempelis, James F Matthaei, Kate S Montgomery, Selvi Srinivasan, Debashish Roy, Fei Huang, Shannon A Kreuser, Jennifer L Gardell, Ian Blumenthal, John Chiefari, Michael C Jensen, Courtney A Crane, Patrick S Stayton
Arming Immune Cell Therapeutics with Polymeric Prodrugs. Advanced healthcare materials (2021)
Katherine J Brempelis, Courtney M Cowan, Shannon A Kreuser, Kevin P Labadie, Brooke M Prieskorn, Nicole A P Lieberman, Chibawanye I Ene, Kara W Moyes, Harrison Chinn, Kole R DeGolier, Lisa R Matsumoto, Sara K Daniel, Jason K Yokoyama, Amira D Davis, Virginia J Hoglund, Kimberly S Smythe, Stephanie D Balcaitis, Michael C Jensen, Richard G Ellenbogen, Jean S Campbell, Robert H Pierce, Eric C Holland, Venu G Pillarisetty, Courtney A Crane
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. Journal for immunotherapy of cancer 8 (2) (2021)

Katherine J Brempelis.css-eqlu8i{font-size:small;padding-left:4px;}